EPOCH regimen

DRUG4 trials

Sponsors

Medstar Health Research Institute, German High-Grade Non-Hodgkin's Lymphoma Study Group, European Organisation for Research and Treatment of Cancer - EORTC, Ohio State University Comprehensive Cancer Center

Conditions

Lymphoma

Phase 2

Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma

TerminatedNCT00060385

European Organisation for Research and Treatment of Cancer - EORTCLymphoma

Start: 2003-03-31Updated: 2012-09-24

Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma

WithdrawnNCT00006669

Medstar Health Research InstituteLymphoma

Start: 1999-09-30End: 2000-01-31Updated: 2021-10-27

Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma

WithdrawnNCT00983944

Ohio State University Comprehensive Cancer CenterLymphoma

Start: 2009-09-30End: 2011-04-25Updated: 2017-11-30

Phase 3

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

CompletedNCT00053768

German High-Grade Non-Hodgkin's Lymphoma Study GroupLymphoma

Start: 2002-04-30End: 2006-12-05Updated: 2021-05-18